Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Fox NC"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 129
Tytuł:
Updating the study protocol: Insight 46 - a longitudinal neuroscience sub-study of the MRC National Survey of Health and Development - phases 2 and 3.
Autorzy:
Murray-Smith H; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK. .
Barker S; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Barkhof F; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands.; Centre for Medical Image Computing, University College London, London, UK.; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
Barnes J; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Brown TM; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Captur G; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
R E Cartlidge M; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Cash DM; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.; Centre for Medical Image Computing, University College London, London, UK.
Coath W; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Davis D; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
Dickson JC; Institute of Nuclear Medicine, University College London Hospitals, London, UK.
Groves J; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Hughes AD; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
James SN; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
Keshavan A; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Keuss SE; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
King-Robson J; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Lu K; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Malone IB; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Nicholas JM; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
Rapala A; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
Scott CJ; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.; Institute of Nuclear Medicine, University College London Hospitals, London, UK.
Street R; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Sudre CH; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.; Centre for Medical Image Computing, University College London, London, UK.; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
Thomas DL; Neuroradiological Academic Unit, UCL Queen Square Institute of Neurology, University College London, London, UK.
Wong A; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
Wray S; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
Zetterberg H; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.; UK Dementia Research Institute, University College London, London, UK.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Hong, Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.
Chaturvedi N; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
Fox NC; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Crutch SJ; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Richards M; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
Schott JM; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Pokaż więcej
Źródło:
BMC neurology [BMC Neurol] 2024 Jan 23; Vol. 24 (1), pp. 40. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:
Journal Article
MeSH Terms:
Dementia*
Aged ; Female ; Humans ; Male ; Aging ; Ambulatory Care ; Brain ; Observational Studies as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease.
Autorzy:
Schultz SA; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Shirzadi Z; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Schultz AP; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Liu L; Brigham and Women's Hospital, Boston, Massachusetts, USA.; Ann Romney Center for Neurologic Diseases, Boston, Massachusetts, USA.
Fitzpatrick CD; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
McDade E; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Barthelemy NR; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Renton A; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Esposito B; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Joseph-Mathurin N; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Cruchaga C; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Chen CD; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Goate A; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Allegri RF; INEBA, Buenos Aires, Argentina.
Benzinger TLS; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Berman S; University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Chui HC; Department of Neurology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Fagan AM; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Farlow MR; Indiana Alzheimer's Disease Research Center, Indianapolis, Indiana, USA.
Fox NC; Dementia Research Centre & UK Dementia Research Institute, UCL Institute of Neurology, London, UK.
Gordon BA; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Day GS; Mayo Clinic, Jacksonville, Florida, USA.
Graff-Radford NR; Mayo Clinic, Jacksonville, Florida, USA.
Hassenstab JJ; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Hanseeuw BJ; Institute of Neuroscience, UCLouvain, Brussels, Belgium.; Gordon Center for Medical Imaging in the Radiology Department of MGH, Boston, Massachusetts, USA.
Hofmann A; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany.
Jack CR Jr; Mayo Clinic, Rochester, Minnesota, USA.
Jucker M; German Center for Neurodegenerative Diseases (DZNE), Tuebingen, Germany.
Karch CM; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Koeppe RA; University of Michigan, Ann Arbor, Michigan, USA.
Lee JH; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
Levey AI; Emory Goizueta Alzheimer's Disease Research Center, Atlanta, Georgia, USA.
Levin J; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.; Department of Neurology, Ludwig-Maximilians-Universität München, Munich, Germany.; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Martins RN; Edith Cowan University, Joondalup, Western Australia, Australia.
Mori H; Osaka City University Medical School, Osaka, Japan.
Morris JC; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Noble J; Columbia University, New York, New York, USA.
Perrin RJ; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Rosa-Neto P; Translational Neuroimaging Laboratory, Le Centre intégré universitaire de santé et de services sociaux (CIUSSS) de l'Ouest-de-l'Île-de-Montréal; Department of Neurology and Neurosurgery, McGill University, Montreal, Canada.
Salloway SP; Butler Hospital, Providence, Rhode Island, USA.
Sanchez-Valle R; Alzheimer's disease and other cognitive disorders Unit, Neurology Department, Hospital Clínic de Barcelona, Institut d'Investigacions Biomediques, Barcelona, Spain.
Schofield PR; Neuroscience Research Australia, Randwick, New South Wales, Australia.; School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia.
Xiong C; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Johnson KA; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Brigham and Women's Hospital, Boston, Massachusetts, USA.
Bateman RJ; Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
Sperling RA; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Brigham and Women's Hospital, Boston, Massachusetts, USA.
Chhatwal JP; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Brigham and Women's Hospital, Boston, Massachusetts, USA.
Pokaż więcej
Corporate Authors:
Dominantly Inherited Alzheimer Network Investigators
Źródło:
Aging cell [Aging Cell] 2023 Aug; Vol. 22 (8), pp. e13871. Date of Electronic Publication: 2023 Jun 08.
Typ publikacji:
Observational Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Presenilin-1*/chemistry
Presenilin-1*/genetics
Presenilin-1*/metabolism
Alzheimer Disease*/genetics
Alzheimer Disease*/metabolism
Alzheimer Disease*/pathology
Humans ; Male ; Female ; Adult ; Brain/metabolism ; Brain/pathology ; Positron-Emission Tomography ; Magnetic Resonance Imaging ; Mutation ; Cognition ; Amyloid beta-Peptides/metabolism ; tau Proteins/metabolism ; Longitudinal Studies ; Cross-Sectional Studies ; Biomarkers
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Tau accumulation in autosomal dominant Alzheimer's disease: a longitudinal [ F]flortaucipir study.
Autorzy:
O'Connor A; Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK. Antoinette.o'.; UK Dementia Research Institute at UCL, London, UK. Antoinette.o'.
Cash DM; Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK.
Poole T; Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK.; Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK.
Markiewicz PJ; Centre for Medical Image Computing, Medical Physics and Biomedical Engineering, UCL, London, UK.
Fraser MR; Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK.
Malone IB; Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK.
Jiao J; Centre for Medical Image Computing, Medical Physics and Biomedical Engineering, UCL, London, UK.
Weston PSJ; Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK.
Flores S; Department of Radiology, Washington University in St. Louis, St. Louis, MO, USA.
Hornbeck R; Department of Radiology, Washington University in St. Louis, St. Louis, MO, USA.
McDade E; Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA.
Schöll M; Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK.; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.
Gordon BA; Department of Radiology, Washington University in St. Louis, St. Louis, MO, USA.
Bateman RJ; Department of Neurology, Washington University in St. Louis, St. Louis, MO, USA.
Benzinger TLS; Department of Radiology, Washington University in St. Louis, St. Louis, MO, USA.
Fox NC; Dementia Research Centre, UCL Queen Square Institute of Neurology, London, UK.; UK Dementia Research Institute at UCL, London, UK.
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2023 May 25; Vol. 15 (1), pp. 99. Date of Electronic Publication: 2023 May 25.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease*/diagnostic imaging
Alzheimer Disease*/genetics
Alzheimer Disease*/complications
Cognitive Dysfunction*/pathology
Humans ; Carbolines ; Longitudinal Studies ; Positron-Emission Tomography/methods ; tau Proteins/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Investigating associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer's disease.
Autorzy:
Green RE; Institute of Psychiatry, Psychology & Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AB, UK.; UK National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre, South London and Maudsley Trust, London, UK.
Lord J; Institute of Psychiatry, Psychology & Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AB, UK.
Scelsi MA; Department of Medical Physics and Biomedical Engineering, Centre for Medical Image Computing (CMIC), University College London (UCL), London, UK.
Xu J; Institute of Psychiatry, Psychology & Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AB, UK.; Institute of Pharmaceutical Science, King's College London, London, UK.
Wong A; MRC Unit for Lifelong Health & Ageing at UCL, University College London, Floor 5, MRC LHA at UCL, 1 - 19 Torrington Place, London, WC1E 7HB, UK.
Naomi-James S; MRC Unit for Lifelong Health & Ageing at UCL, University College London, Floor 5, MRC LHA at UCL, 1 - 19 Torrington Place, London, WC1E 7HB, UK.; Dementia Research Centre, UCL Queen Square Institute of Neurology, 8-11 Queen Square, London, WC1N 3BG, UK.
Handy A; University College London, Institute of Health Informatics, London, UK.
Gilchrist L; Institute of Psychiatry, Psychology & Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AB, UK.
Williams DM; MRC Unit for Lifelong Health & Ageing at UCL, University College London, Floor 5, MRC LHA at UCL, 1 - 19 Torrington Place, London, WC1E 7HB, UK.; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Parker TD; Dementia Research Centre, UCL Queen Square Institute of Neurology, 8-11 Queen Square, London, WC1N 3BG, UK.; Department of Brain Sciences, Imperial College London, London, W12 0NN, UK.; UK DRI Centre for Care Research and Technology, Imperial College London, London, W12 0BZ, UK.
Lane CA; Dementia Research Centre, UCL Queen Square Institute of Neurology, 8-11 Queen Square, London, WC1N 3BG, UK.
Malone IB; Dementia Research Centre, UCL Queen Square Institute of Neurology, 8-11 Queen Square, London, WC1N 3BG, UK.
Cash DM; Dementia Research Centre, UCL Queen Square Institute of Neurology, 8-11 Queen Square, London, WC1N 3BG, UK.; UK Dementia Research Institute at University College London, London, UK.
Sudre CH; Department of Medical Physics and Biomedical Engineering, Centre for Medical Image Computing (CMIC), University College London (UCL), London, UK.; MRC Unit for Lifelong Health & Ageing at UCL, University College London, Floor 5, MRC LHA at UCL, 1 - 19 Torrington Place, London, WC1E 7HB, UK.; Dementia Research Centre, UCL Queen Square Institute of Neurology, 8-11 Queen Square, London, WC1N 3BG, UK.; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Coath W; Dementia Research Centre, UCL Queen Square Institute of Neurology, 8-11 Queen Square, London, WC1N 3BG, UK.
Thomas DL; Dementia Research Centre, UCL Queen Square Institute of Neurology, 8-11 Queen Square, London, WC1N 3BG, UK.; Neuroradiological Academic Unit, Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, University College London, London, UK.
Keuss S; Dementia Research Centre, UCL Queen Square Institute of Neurology, 8-11 Queen Square, London, WC1N 3BG, UK.
Dobson R; Institute of Psychiatry, Psychology & Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AB, UK.; UK National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre, South London and Maudsley Trust, London, UK.; University College London, Institute of Health Informatics, London, UK.; Health Data Research UK London, University College London, London, UK.; NIHR Biomedical Research Centre at University College London Hospitals NHS Foundation Trust, London, UK.
Legido-Quigley C; Institute of Pharmaceutical Science, King's College London, London, UK.; Steno Diabetes Center Copenhagen, Gentofte, Denmark.
Fox NC; Dementia Research Centre, UCL Queen Square Institute of Neurology, 8-11 Queen Square, London, WC1N 3BG, UK.; UK Dementia Research Institute at University College London, London, UK.
Schott JM; Dementia Research Centre, UCL Queen Square Institute of Neurology, 8-11 Queen Square, London, WC1N 3BG, UK. .
Richards M; MRC Unit for Lifelong Health & Ageing at UCL, University College London, Floor 5, MRC LHA at UCL, 1 - 19 Torrington Place, London, WC1E 7HB, UK. .
Proitsi P; Institute of Psychiatry, Psychology & Neuroscience, King's College London, 16 De Crespigny Park, London, SE5 8AB, UK. .
Pokaż więcej
Corporate Authors:
Insight 46 study team
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2023 Feb 22; Vol. 15 (1), pp. 38. Date of Electronic Publication: 2023 Feb 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease*/genetics
Aged ; Humans ; Middle Aged ; Amyloid beta-Peptides/metabolism ; Apolipoproteins E/metabolism ; Brain/metabolism ; Lipids ; Neuroimaging ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Herpes simplex virus and rates of cognitive decline or whole brain atrophy in the Dominantly Inherited Alzheimer Network.
Autorzy:
Warren-Gash C; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Cadogan SL; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Nicholas JM; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Breuer JM; Institute of Child Health, University College London, Gower Street, London, WC1E 6BT, United Kingdom.; Virology Department, Great Ormond Street Hospital, London, United Kingdom.
Shah D; Virology Department, Great Ormond Street Hospital, London, United Kingdom.
Pearce N; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Shiekh S; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Smeeth L; Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Farlow MR; Indiana University School of Medicine, Indianapolis, Indiana, USA.
Mori H; Department of Clinical Neuroscience, Osaka Metropolitan University Medical School, Sutoku University, Osaka, Japan.
Gordon BA; Department of Radiology, Washington University School of Medicine in St Louis, Missouri, USA.
Nuebling G; German Center for Neurodegenerative Diseases, Site Munich, Germany.; Department of Neurology, Ludwig-Maximilians University, Munich, Germany.
McDade E; Department of Neurology, Washington University School of Medicine, St. Louis, USA.
Bateman RJ; Department of Neurology, Washington University School of Medicine, St. Louis, USA.
Schofield PR; Neuroscience Research Australia, Sydney, New South Wales, Australia.; School of Medical Sciences, University of New South Wales, Sydney, New South Wales, Australia.
Lee JH; Department of Neurology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
Morris JC; Department of Neurology, Washington University School of Medicine, St. Louis, USA.
Cash DM; UK Dementia Research Institute, University College London, London, United Kingdom.; Dementia Research Centre, Institute of Neurology, University College London, Queen Square, London, United Kingdom.
Fox NC; Dementia Research Centre, Institute of Neurology, University College London, Queen Square, London, United Kingdom.; NIHR University College London Hospitals Biomedical Research Centre, London, United Kingdom.
Ridha BH; Dementia Research Centre, Institute of Neurology, University College London, Queen Square, London, United Kingdom.; NIHR University College London Hospitals Biomedical Research Centre, London, United Kingdom.
Rossor MN; Dementia Research Centre, Institute of Neurology, University College London, Queen Square, London, United Kingdom.; NIHR University College London Hospitals Biomedical Research Centre, London, United Kingdom.
Pokaż więcej
Corporate Authors:
Dominantly Inherited Alzheimer Network
Źródło:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2022 Nov; Vol. 9 (11), pp. 1727-1738. Date of Electronic Publication: 2022 Oct 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease*/genetics
Alzheimer Disease*/diagnosis
Cognitive Dysfunction*/genetics
Cognitive Dysfunction*/pathology
Humans ; Young Adult ; Adult ; Middle Aged ; Aged ; Simplexvirus ; Atrophy/pathology ; Brain/diagnostic imaging ; Brain/pathology ; Immunoglobulin G ; Immunoglobulin M
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Imaging tau pathology in Alzheimer's disease with positron emission tomography: lessons learned from imaging-neuropathology validation studies.
Autorzy:
Moscoso A; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.
Wren MC; Department of Imaging, Centre for Radiopharmaceutical Chemistry, University College London, London, UK.; Department of Chemistry, University College London, London, UK.; Queen Square Brain Bank for Neurological Disorders, Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, London, UK.; Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London, London, UK.
Lashley T; Queen Square Brain Bank for Neurological Disorders, Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, University College London, London, UK.; Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London, London, UK.
Arstad E; Department of Imaging, Centre for Radiopharmaceutical Chemistry, University College London, London, UK.; Department of Chemistry, University College London, London, UK.
Murray ME; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Fox NC; Dementia Research Centre, Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London, London, UK.; UK Dementia Research Institute, Queen Square Institute of Neurology, University College London, London, UK.
Sander K; Department of Imaging, Centre for Radiopharmaceutical Chemistry, University College London, London, UK.; Department of Chemistry, University College London, London, UK.
Schöll M; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. .; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden. .; Dementia Research Centre, Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London, London, UK. .; Department of Clinical Physiology, Sahlgrenska University Hospital, Röda stråket 10B, 413 45, Gothenburg, Sweden. .
Pokaż więcej
Źródło:
Molecular neurodegeneration [Mol Neurodegener] 2022 Jun 03; Vol. 17 (1), pp. 39. Date of Electronic Publication: 2022 Jun 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Alzheimer Disease*/diagnostic imaging
Alzheimer Disease*/pathology
Amyloid beta-Peptides/metabolism ; Brain/metabolism ; Humans ; Positron-Emission Tomography/methods ; tau Proteins/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Investigating the relationship between BMI across adulthood and late life brain pathologies.
Autorzy:
Lane CA; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, Box 16, Queen Square, London, WC1N 3BG, UK.; Hoffmann-La Roche UK Ltd, London, UK.
Barnes J; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, Box 16, Queen Square, London, WC1N 3BG, UK.
Nicholas JM; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, Box 16, Queen Square, London, WC1N 3BG, UK.; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, University of London, London, UK.
Baker JW; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, Box 16, Queen Square, London, WC1N 3BG, UK.
Sudre CH; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, Box 16, Queen Square, London, WC1N 3BG, UK.; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Cash DM; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, Box 16, Queen Square, London, WC1N 3BG, UK.
Parker TD; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, Box 16, Queen Square, London, WC1N 3BG, UK.
Malone IB; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, Box 16, Queen Square, London, WC1N 3BG, UK.
Lu K; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, Box 16, Queen Square, London, WC1N 3BG, UK.
James SN; MRC Unit for Lifelong Health and Ageing at UCL, London, UK.
Keshavan A; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, Box 16, Queen Square, London, WC1N 3BG, UK.
Buchanan S; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, Box 16, Queen Square, London, WC1N 3BG, UK.
Keuss S; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, Box 16, Queen Square, London, WC1N 3BG, UK.
Murray-Smith H; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, Box 16, Queen Square, London, WC1N 3BG, UK.
Wong A; MRC Unit for Lifelong Health and Ageing at UCL, London, UK.
Gordon E; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, Box 16, Queen Square, London, WC1N 3BG, UK.
Coath W; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, Box 16, Queen Square, London, WC1N 3BG, UK.
Modat M; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, Box 16, Queen Square, London, WC1N 3BG, UK.; School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.
Thomas D; Leonard Wolfson Experimental Neurology Centre, UCL Queen Square Institute of Neurology, University College London, London, UK.; Neuroradiological Academic Unit, Department of Brain Repair and Rehabilitation, UCL Queen Square Institute of Neurology, University College London, London, UK.
Hardy R; MRC Unit for Lifelong Health and Ageing at UCL, London, UK.
Richards M; MRC Unit for Lifelong Health and Ageing at UCL, London, UK.
Fox NC; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, Box 16, Queen Square, London, WC1N 3BG, UK.; UK Dementia Research Institute at UCL, University College London, London, UK.
Schott JM; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, Box 16, Queen Square, London, WC1N 3BG, UK. .; UK Dementia Research Institute at UCL, University College London, London, UK. .
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2021 Apr 30; Vol. 13 (1), pp. 91. Date of Electronic Publication: 2021 Apr 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease*
Adult ; Aged ; Amyloid beta-Peptides/metabolism ; Body Mass Index ; Brain/diagnostic imaging ; Brain/metabolism ; Cross-Sectional Studies ; Humans ; Middle Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Eye-tracking indices of impaired encoding of visual short-term memory in familial Alzheimer's disease.
Autorzy:
Pavisic IM; Department of Neurodegenerative Diseases, Dementia Research Centre, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK. .; UK Dementia Research Institute at University College London, London, UK. .
Pertzov Y; Department of Psychology, The Hebrew University of Jerusalem, Jerusalem, Israel.
Nicholas JM; Department of Neurodegenerative Diseases, Dementia Research Centre, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.; Department of Medial Statistics, London School of Hygiene and Tropical Medicine, London, UK.
O'Connor A; Department of Neurodegenerative Diseases, Dementia Research Centre, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.; UK Dementia Research Institute at University College London, London, UK.
Lu K; Department of Neurodegenerative Diseases, Dementia Research Centre, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
Yong KXX; Department of Neurodegenerative Diseases, Dementia Research Centre, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
Husain M; Nuffield Department of Clinical Neuroscience, University of Oxford, Oxford, UK.; Department of Experimental Psychology, University of Oxford, Oxford, UK.
Fox NC; Department of Neurodegenerative Diseases, Dementia Research Centre, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.; UK Dementia Research Institute at University College London, London, UK.
Crutch SJ; Department of Neurodegenerative Diseases, Dementia Research Centre, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.; UK Dementia Research Institute at University College London, London, UK.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Apr 22; Vol. 11 (1), pp. 8696. Date of Electronic Publication: 2021 Apr 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Eye Movements*
Eye-Tracking Technology*
Memory, Short-Term*
Visual Perception*
Alzheimer Disease/*physiopathology
Alzheimer Disease/genetics ; Case-Control Studies ; Cohort Studies ; Female ; Genetic Predisposition to Disease ; Humans ; Male ; Photic Stimulation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A population-based study of head injury, cognitive function and pathological markers.
Autorzy:
James SN; MRC Unit for Lifelong Health and Ageing at UCL, University College London, London, United Kingdom.; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Nicholas JM; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Lane CA; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Parker TD; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Lu K; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Keshavan A; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Buchanan SM; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Keuss SE; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Murray-Smith H; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Wong A; MRC Unit for Lifelong Health and Ageing at UCL, University College London, London, United Kingdom.
Cash DM; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Malone IB; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Barnes J; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Sudre CH; MRC Unit for Lifelong Health and Ageing at UCL, University College London, London, United Kingdom.; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.; School of Biomedical Engineering and Imaging Sciences, King's College London, Institute of Nuclear Medicine, University College London Hospitals, London, United Kingdom.; Centre for Medical Image Computing, Department of Computer Science, University College London, London, United Kingdom.
Coath W; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Prosser L; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Ourselin S; School of Biomedical Engineering and Imaging Sciences, King's College London, Institute of Nuclear Medicine, University College London Hospitals, London, United Kingdom.
Modat M; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.; School of Biomedical Engineering and Imaging Sciences, King's College London, Institute of Nuclear Medicine, University College London Hospitals, London, United Kingdom.
Thomas DL; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Cardoso J; School of Biomedical Engineering and Imaging Sciences, King's College London, Institute of Nuclear Medicine, University College London Hospitals, London, United Kingdom.
Heslegrave A; UK Dementia Research Institute at UCL, University College London, London, United Kingdom.; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, United Kingdom.
Zetterberg H; UK Dementia Research Institute at UCL, University College London, London, United Kingdom.; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, United Kingdom.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Crutch SJ; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Schott JM; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
Richards M; MRC Unit for Lifelong Health and Ageing at UCL, University College London, London, United Kingdom.
Fox NC; Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.; UK Dementia Research Institute at UCL, University College London, London, United Kingdom.
Pokaż więcej
Źródło:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2021 Apr; Vol. 8 (4), pp. 842-856. Date of Electronic Publication: 2021 Mar 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Aging*/physiology
Cognitive Dysfunction*/diagnosis
Cognitive Dysfunction*/etiology
Cognitive Dysfunction*/pathology
Cognitive Dysfunction*/physiopathology
Craniocerebral Trauma*/complications
Craniocerebral Trauma*/pathology
Craniocerebral Trauma*/physiopathology
Unconsciousness*/etiology
Aged ; Cohort Studies ; Female ; Humans ; Magnetic Resonance Imaging ; Male ; Positron-Emission Tomography
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Quantitative detection and staging of presymptomatic cognitive decline in familial Alzheimer's disease: a retrospective cohort analysis.
Autorzy:
O'Connor A; Dementia Research Centre, UCL Queen Square Institute Of Neurology, 8-11 Queen Square, London, WC1N 3AR, UK. antoinette.o'.; UK Dementia Research Institute at UCL, UCL, London, UK. antoinette.o'.
Weston PSJ; Dementia Research Centre, UCL Queen Square Institute Of Neurology, 8-11 Queen Square, London, WC1N 3AR, UK.
Pavisic IM; Dementia Research Centre, UCL Queen Square Institute Of Neurology, 8-11 Queen Square, London, WC1N 3AR, UK.; UK Dementia Research Institute at UCL, UCL, London, UK.
Ryan NS; Dementia Research Centre, UCL Queen Square Institute Of Neurology, 8-11 Queen Square, London, WC1N 3AR, UK.; UK Dementia Research Institute at UCL, UCL, London, UK.
Collins JD; Dementia Research Centre, UCL Queen Square Institute Of Neurology, 8-11 Queen Square, London, WC1N 3AR, UK.
Lu K; Dementia Research Centre, UCL Queen Square Institute Of Neurology, 8-11 Queen Square, London, WC1N 3AR, UK.
Crutch SJ; Dementia Research Centre, UCL Queen Square Institute Of Neurology, 8-11 Queen Square, London, WC1N 3AR, UK.
Alexander DC; Department of Computer Science, UCL Centre for Medical Image Computing, 1st Floor, 90 High Holborn, London, WC1V 6LJ, UK.
Fox NC; Dementia Research Centre, UCL Queen Square Institute Of Neurology, 8-11 Queen Square, London, WC1N 3AR, UK.; UK Dementia Research Institute at UCL, UCL, London, UK.
Oxtoby NP; Department of Computer Science, UCL Centre for Medical Image Computing, 1st Floor, 90 High Holborn, London, WC1V 6LJ, UK. .
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2020 Oct 06; Vol. 12 (1), pp. 126. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease*/complications
Alzheimer Disease*/genetics
Cognitive Dysfunction*/genetics
Cohort Studies ; Humans ; Neuropsychological Tests ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Measuring cortical mean diffusivity to assess early microstructural cortical change in presymptomatic familial Alzheimer's disease.
Autorzy:
Weston PSJ; Dementia Research Centre, UCL Institute of Neurology, Queen Square, Box 16, London, WC1N 3BG, UK. .
Poole T; Dementia Research Centre, UCL Institute of Neurology, Queen Square, Box 16, London, WC1N 3BG, UK.; Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK.
Nicholas JM; Dementia Research Centre, UCL Institute of Neurology, Queen Square, Box 16, London, WC1N 3BG, UK.; Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK.
Toussaint N; Dementia Research Centre, UCL Institute of Neurology, Queen Square, Box 16, London, WC1N 3BG, UK.; Transitional Imaging Group, Centre for Medical Image Computing, University College London, London, UK.
Simpson IJA; Dementia Research Centre, UCL Institute of Neurology, Queen Square, Box 16, London, WC1N 3BG, UK.; Transitional Imaging Group, Centre for Medical Image Computing, University College London, London, UK.
Modat M; Dementia Research Centre, UCL Institute of Neurology, Queen Square, Box 16, London, WC1N 3BG, UK.; Department of Biomedical Engineering & Imaging Sciences, King's College London, London, UK.
Ryan NS; Dementia Research Centre, UCL Institute of Neurology, Queen Square, Box 16, London, WC1N 3BG, UK.
Liang Y; Dementia Research Centre, UCL Institute of Neurology, Queen Square, Box 16, London, WC1N 3BG, UK.
Rossor MN; Dementia Research Centre, UCL Institute of Neurology, Queen Square, Box 16, London, WC1N 3BG, UK.
Schott JM; Dementia Research Centre, UCL Institute of Neurology, Queen Square, Box 16, London, WC1N 3BG, UK.
Ourselin S; Dementia Research Centre, UCL Institute of Neurology, Queen Square, Box 16, London, WC1N 3BG, UK.; Department of Biomedical Engineering & Imaging Sciences, King's College London, London, UK.
Zhang H; Microstructure Imaging Group, Centre for Medical Image Computing, University College London, London, UK.
Fox NC; Dementia Research Centre, UCL Institute of Neurology, Queen Square, Box 16, London, WC1N 3BG, UK.
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2020 Sep 17; Vol. 12 (1), pp. 112. Date of Electronic Publication: 2020 Sep 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease*/diagnostic imaging
Alzheimer Disease*/genetics
Diffusion Magnetic Resonance Imaging ; Heterozygote ; Humans ; Magnetic Resonance Imaging
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Neuronal intranuclear inclusion disease is genetically heterogeneous.
Autorzy:
Chen Z; Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK.; Department of Neuromuscular Disease, Queen Square Institute of Neurology, UCL, London, UK.
Yan Yau W; Department of Neuromuscular Disease, Queen Square Institute of Neurology, UCL, London, UK.
Jaunmuktane Z; Queen Square Brain Bank, Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, UCL, UK.
Tucci A; Clinical Pharmacology, William Harvey Research Institute, School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Sivakumar P; Department of Neuromuscular Disease, Queen Square Institute of Neurology, UCL, London, UK.
Gagliano Taliun SA; Center for Statistical Genetics and Department of Biostatistics, University of Michigan, Ann Arbor, Michigan.
Turner C; Queen Square Institute of Neurology, UCL and the National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
Efthymiou S; Department of Neuromuscular Disease, Queen Square Institute of Neurology, UCL, London, UK.
Ibáñez K; Clinical Pharmacology, William Harvey Research Institute, School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Sullivan R; Department of Neuromuscular Disease, Queen Square Institute of Neurology, UCL, London, UK.
Bibi F; University Institute of Biochemistry & Biotechnology, PMAS - Arid Agriculture University, Rawalpindi, Pakistan.
Athanasiou-Fragkouli A; Department of Neuromuscular Disease, Queen Square Institute of Neurology, UCL, London, UK.
Bourinaris T; Department of Neuromuscular Disease, Queen Square Institute of Neurology, UCL, London, UK.
Zhang D; Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK.
Revesz T; Queen Square Brain Bank, Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, UCL, UK.
Lashley T; Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK.; Queen Square Brain Bank, Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, UCL, UK.
DeTure M; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida.
Dickson DW; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida.
Josephs KA; Mayo Clinic, Neurodegenerative Research Group, Rochester, Minnesota.
Gelpi E; Neurological Tissue Bank of the Hospital Clinic-Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS) Biobank, Barcelona, Spain.; Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Austria.
Kovacs GG; Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Austria.; University of Toronto, Tanz Centre for Research in Neurodegenerative Disease, Toronto, Canada.
Halliday G; Neuroscience Research Australia, Sydney, Australia.; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia.; Brain and Mind Centre, Sydney Medical School, The University of Sydney, Sydney, Australia.
Rowe DB; Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.
Blair I; Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.
Tienari PJ; Department of Neurology, Helsinki University Hospital, Helsinki, Finland.; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Suomalainen A; Research Programs Unit, Stem Cells and Metabolism, University of Helsinki, Helsinki, 00290, Finland.; Neuroscience Center, HiLife, University of Helsinki, Helsinki, 00290, Finland.; HUSlab, Helsinki University Hospital, Helsinki, 00290, Finland.
Fox NC; Dementia Research Centre, UCL, London, Queen Square, UK.
Wood NW; Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, UCL, London, UK.
Lees AJ; Queen Square Brain Bank, Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, UCL, UK.; Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, Wakefield Street, London.
Haltia MJ; Department of Pathology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Hardy J; Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK.; Reta Lila Weston Institute, UCL Queen Square Institute of Neurology, Wakefield Street, London.; UK Dementia Research Institute at UCL, Queen Square Institute of Neurology, UCL, London, UK.; NIHR University College London Hospitals Biomedical Research Centre, London, UK.; Institute for Advanced Study, The Hong Kong University of Science and Technology, Hong Kong SAR, China.
Ryten M; Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK.
Vandrovcova J; Department of Neuromuscular Disease, Queen Square Institute of Neurology, UCL, London, UK.
Houlden H; Department of Neuromuscular Disease, Queen Square Institute of Neurology, UCL, London, UK.
Pokaż więcej
Corporate Authors:
Genomics England Research Consortium; Genomics England, London, UK.; William Harvey Research Institute, Queen Mary University of London, London, EC1M 6BQ, UK.
Źródło:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2020 Sep; Vol. 7 (9), pp. 1716-1725. Date of Electronic Publication: 2020 Aug 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Neurodegenerative Diseases/*genetics
Neurodegenerative Diseases/*physiopathology
Receptor, Notch2/*genetics
Adolescent ; Adult ; Age of Onset ; Europe ; Female ; Humans ; Intranuclear Inclusion Bodies/genetics ; Male ; Middle Aged ; Polymorphism, Single Nucleotide ; Trinucleotide Repeat Expansion ; White People ; Whole Genome Sequencing
SCR Disease Name:
Neuronal intranuclear inclusion disease
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Imaging biomarkers in neurodegeneration: current and future practices.
Autorzy:
Young PNE; Wallenberg Centre for Molecular and Translational Medicine and the Department of Psychiatry and Neurochemistry, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
Estarellas M; Centre for Medical Image Computing (CMIC), Department of Computer Science & Department of Medical Physics and Biomedical Engineering, University College London, London, UK.
Coomans E; Department of Radiology and Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands.
Srikrishna M; Wallenberg Centre for Molecular and Translational Medicine and the Department of Psychiatry and Neurochemistry, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
Beaumont H; Neuroscience and Aphasia Research Unit, Division of Neuroscience and Experimental Psychology, The University of Manchester, Manchester, UK.
Maass A; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
Venkataraman AV; Division of Brain Sciences, Imperial College London, London, UK.; United Kingdom Dementia Research Institute, Imperial College London, London, UK.
Lissaman R; Cardiff University Brain Research Imaging Centre (CUBRIC), School of Psychology, Cardiff, UK.
Jiménez D; Dementia Research Centre, UCL Institute of Neurology, University College London, London, UK.; Department of Neurological Sciences, Faculty of Medicine, University of Chile, Santiago, Chile.
Betts MJ; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.; Institute of Cognitive Neurology and Dementia Research, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.
McGlinchey E; Trinity College Dublin, The University of Dublin, Dublin, Ireland.
Berron D; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
O'Connor A; Dementia Research Centre, UCL Institute of Neurology, University College London, London, UK.
Fox NC; Dementia Research Centre, UCL Institute of Neurology, University College London, London, UK.
Pereira JB; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.; Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden.
Jagust W; Helen Wills Neuroscience Institute, University of California, Berkeley, USA.; Molecular Biophysics and Integrated Bioimaging, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Carter SF; Department of Psychiatry, School of Clinical Medicine, University of Cambridge, Cambridge, UK.; Wolfson Molecular Imaging Centre, Division of Neuroscience and Experimental Psychology, MAHSC, University of Manchester, Manchester, UK.
Paterson RW; Dementia Research Centre, UCL Institute of Neurology, University College London, London, UK.
Schöll M; Wallenberg Centre for Molecular and Translational Medicine and the Department of Psychiatry and Neurochemistry, University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden. .; Dementia Research Centre, UCL Institute of Neurology, University College London, London, UK. .; Department of Clinical Physiology, Sahlgrenska University Hospital, Gothenburg, Sweden. .
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2020 Apr 27; Vol. 12 (1), pp. 49. Date of Electronic Publication: 2020 Apr 27.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Alzheimer Disease*
Neuroimaging*
Biomarkers ; Humans ; Magnetic Resonance Imaging ; Positron-Emission Tomography
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CSF synaptic protein concentrations are raised in those with atypical Alzheimer's disease but not frontotemporal dementia.
Autorzy:
Clarke MTM; Dementia Research Centre, Department of Neurodegenerative Disease, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
Brinkmalm A; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Foiani MS; UK Dementia Research Institute at UCL, London, UK.; Department of Neurodegenerative Disease, University College London, London, UK.
Woollacott IOC; Dementia Research Centre, Department of Neurodegenerative Disease, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
Heller C; UK Dementia Research Institute at UCL, London, UK.; Department of Neurodegenerative Disease, University College London, London, UK.
Heslegrave A; UK Dementia Research Institute at UCL, London, UK.; Department of Neurodegenerative Disease, University College London, London, UK.
Keshavan A; Dementia Research Centre, Department of Neurodegenerative Disease, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
Fox NC; Dementia Research Centre, Department of Neurodegenerative Disease, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
Schott JM; Dementia Research Centre, Department of Neurodegenerative Disease, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
Warren JD; Dementia Research Centre, Department of Neurodegenerative Disease, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; UK Dementia Research Institute at UCL, London, UK.; Department of Neurodegenerative Disease, University College London, London, UK.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Rohrer JD; Dementia Research Centre, Department of Neurodegenerative Disease, University College London, Queen Square Institute of Neurology, London, WC1N 3BG, UK. .
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2019 Dec 17; Vol. 11 (1), pp. 105. Date of Electronic Publication: 2019 Dec 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease/*cerebrospinal fluid
Frontotemporal Dementia/*cerebrospinal fluid
Neurogranin/*cerebrospinal fluid
Synaptosomal-Associated Protein 25/*cerebrospinal fluid
Synaptotagmin I/*cerebrospinal fluid
Aged ; Amyloid beta-Peptides/cerebrospinal fluid ; Biomarkers/cerebrospinal fluid ; Female ; Humans ; Male ; Middle Aged ; Peptide Fragments/cerebrospinal fluid ; tau Proteins/cerebrospinal fluid
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Hippocampal subfield volumes and pre-clinical Alzheimer's disease in 408 cognitively normal adults born in 1946.
Autorzy:
Parker TD; The Dementia Research Centre, Queen Square Institute of Neurology, University College London, London, United Kingdom.
Cash DM; The Dementia Research Centre, Queen Square Institute of Neurology, University College London, London, United Kingdom.
Lane CAS; The Dementia Research Centre, Queen Square Institute of Neurology, University College London, London, United Kingdom.
Lu K; The Dementia Research Centre, Queen Square Institute of Neurology, University College London, London, United Kingdom.
Malone IB; The Dementia Research Centre, Queen Square Institute of Neurology, University College London, London, United Kingdom.
Nicholas JM; The Dementia Research Centre, Queen Square Institute of Neurology, University College London, London, United Kingdom.; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom.
James SN; MRC Unit for Lifelong Health and Ageing at University College London, London, United Kingdom.
Keshavan A; The Dementia Research Centre, Queen Square Institute of Neurology, University College London, London, United Kingdom.
Murray-Smith H; The Dementia Research Centre, Queen Square Institute of Neurology, University College London, London, United Kingdom.
Wong A; MRC Unit for Lifelong Health and Ageing at University College London, London, United Kingdom.
Buchanan SM; The Dementia Research Centre, Queen Square Institute of Neurology, University College London, London, United Kingdom.
Keuss SE; The Dementia Research Centre, Queen Square Institute of Neurology, University College London, London, United Kingdom.
Sudre CH; The Dementia Research Centre, Queen Square Institute of Neurology, University College London, London, United Kingdom.; School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom.; Department of Medical Physics and Biomedical Engineering, University College London, London, United Kingdom.
Modat M; The Dementia Research Centre, Queen Square Institute of Neurology, University College London, London, United Kingdom.; School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom.; Department of Medical Physics and Biomedical Engineering, University College London, London, United Kingdom.
Thomas DL; Leonard Wolfson Experimental Neurology Centre, Queen Square Institute of Neurology, University College London, London, United Kingdom.; Neuroradiological Academic Unit, Department of Brain Repair and Rehabilitation, Queen Square Institute of Neurology, University College London, London, United Kingdom.
Crutch SJ; The Dementia Research Centre, Queen Square Institute of Neurology, University College London, London, United Kingdom.
Richards M; MRC Unit for Lifelong Health and Ageing at University College London, London, United Kingdom.
Fox NC; The Dementia Research Centre, Queen Square Institute of Neurology, University College London, London, United Kingdom.
Schott JM; The Dementia Research Centre, Queen Square Institute of Neurology, University College London, London, United Kingdom.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2019 Oct 17; Vol. 14 (10), pp. e0224030. Date of Electronic Publication: 2019 Oct 17 (Print Publication: 2019).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease/*pathology
Hippocampus/*physiology
Aged ; Amyloid/metabolism ; Cross-Sectional Studies ; Female ; Hippocampus/diagnostic imaging ; Humans ; Logistic Models ; Magnetic Resonance Imaging ; Male ; Parahippocampal Gyrus/diagnostic imaging ; Parahippocampal Gyrus/physiology ; Positron-Emission Tomography
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer's disease.
Autorzy:
Weston PSJ; Dementia Research Centre, Department of Neurodegenerative Diseases, UCL Institute of Neurology, Queen Square, Box 16, London, WC1N 3BG, UK. .
Poole T; Dementia Research Centre, Department of Neurodegenerative Diseases, UCL Institute of Neurology, Queen Square, Box 16, London, WC1N 3BG, UK.; Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK.
O'Connor A; Dementia Research Centre, Department of Neurodegenerative Diseases, UCL Institute of Neurology, Queen Square, Box 16, London, WC1N 3BG, UK.
Heslegrave A; The UK Dementia Research Institute at UCL and Department of Neurodegenerative Diseases, UCL Institute of Neurology, London, UK.
Ryan NS; Dementia Research Centre, Department of Neurodegenerative Diseases, UCL Institute of Neurology, Queen Square, Box 16, London, WC1N 3BG, UK.
Liang Y; Dementia Research Centre, Department of Neurodegenerative Diseases, UCL Institute of Neurology, Queen Square, Box 16, London, WC1N 3BG, UK.
Druyeh R; Dementia Research Centre, Department of Neurodegenerative Diseases, UCL Institute of Neurology, Queen Square, Box 16, London, WC1N 3BG, UK.
Mead S; MRC Prion Unit at UCL, Institute of Prion Diseases, London, UK.
Blennow K; Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Schott JM; Dementia Research Centre, Department of Neurodegenerative Diseases, UCL Institute of Neurology, Queen Square, Box 16, London, WC1N 3BG, UK.
Frost C; Dementia Research Centre, Department of Neurodegenerative Diseases, UCL Institute of Neurology, Queen Square, Box 16, London, WC1N 3BG, UK.; Department of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK.
Zetterberg H; The UK Dementia Research Institute at UCL and Department of Neurodegenerative Diseases, UCL Institute of Neurology, London, UK.; Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Fox NC; Dementia Research Centre, Department of Neurodegenerative Diseases, UCL Institute of Neurology, Queen Square, Box 16, London, WC1N 3BG, UK.; The UK Dementia Research Institute at UCL and Department of Neurodegenerative Diseases, UCL Institute of Neurology, London, UK.
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2019 Feb 20; Vol. 11 (1), pp. 19. Date of Electronic Publication: 2019 Feb 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Prodromal Symptoms*
Alzheimer Disease/*blood
Alzheimer Disease/*genetics
Neurofilament Proteins/*blood
Neurofilament Proteins/*genetics
Adult ; Alzheimer Disease/diagnosis ; Biomarkers/blood ; Female ; Heterozygote ; Humans ; Longitudinal Studies ; Male ; Middle Aged
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Polygenic risk and hazard scores for Alzheimer's disease prediction.
Autorzy:
Leonenko G; MRC Centre for Neuropsychiatric Genetics and Genomics Cardiff University Cardiff United Kingdom.
Sims R; MRC Centre for Neuropsychiatric Genetics and Genomics Cardiff University Cardiff United Kingdom.
Shoai M; Institute of Neurology University College London London United Kingdom.
Frizzati A; MRC Centre for Neuropsychiatric Genetics and Genomics Cardiff University Cardiff United Kingdom.
Bossù P; Department of Clinical and Behavioral Neurology Experimental Neuropsychobiology Laboratory IRCCS Santa Lucia Foundation Rome Italy.
Spalletta G; Department of Clinical and Behavioral Neurology Experimental Neuropsychobiology Laboratory IRCCS Santa Lucia Foundation Rome Italy.
Fox NC; Institute of Neurology University College London London United Kingdom.
Williams J; MRC Centre for Neuropsychiatric Genetics and Genomics Cardiff University Cardiff United Kingdom.; UK Dementia Research Institute Cardiff University Cardiff United Kingdom.
Hardy J; Institute of Neurology University College London London United Kingdom.
Escott-Price V; MRC Centre for Neuropsychiatric Genetics and Genomics Cardiff University Cardiff United Kingdom.; UK Dementia Research Institute Cardiff University Cardiff United Kingdom.
Pokaż więcej
Corporate Authors:
GERAD consortium
Źródło:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2019 Feb 18; Vol. 6 (3), pp. 456-465. Date of Electronic Publication: 2019 Feb 18 (Print Publication: 2019).
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease/*genetics
Apolipoproteins E/*genetics
Genetic Predisposition to Disease/*genetics
Alzheimer Disease/epidemiology ; Case-Control Studies ; Female ; Genome-Wide Association Study ; Humans ; Male ; Multifactorial Inheritance ; Polymorphism, Single Nucleotide ; Proportional Hazards Models ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Using a birth cohort to study brain health and preclinical dementia: recruitment and participation rates in Insight 46.
Autorzy:
James SN; MRC Unit for Lifelong Health and Ageing at UCL, London, UK. .; Dementia Research Centre, UCL Institute of Neurology, University College London, London, UK. .
Lane CA; Dementia Research Centre, UCL Institute of Neurology, University College London, London, UK.
Parker TD; Dementia Research Centre, UCL Institute of Neurology, University College London, London, UK.
Lu K; Dementia Research Centre, UCL Institute of Neurology, University College London, London, UK.
Collins JD; Dementia Research Centre, UCL Institute of Neurology, University College London, London, UK.
Murray-Smith H; Dementia Research Centre, UCL Institute of Neurology, University College London, London, UK.
Byford M; MRC Unit for Lifelong Health and Ageing at UCL, London, UK.
Wong A; MRC Unit for Lifelong Health and Ageing at UCL, London, UK.
Keshavan A; Dementia Research Centre, UCL Institute of Neurology, University College London, London, UK.
Buchanan S; Dementia Research Centre, UCL Institute of Neurology, University College London, London, UK.
Keuss SE; Dementia Research Centre, UCL Institute of Neurology, University College London, London, UK.
Kuh D; MRC Unit for Lifelong Health and Ageing at UCL, London, UK.
Fox NC; Dementia Research Centre, UCL Institute of Neurology, University College London, London, UK.
Schott JM; Dementia Research Centre, UCL Institute of Neurology, University College London, London, UK.
Richards M; MRC Unit for Lifelong Health and Ageing at UCL, London, UK.
Pokaż więcej
Źródło:
BMC research notes [BMC Res Notes] 2018 Dec 13; Vol. 11 (1), pp. 885. Date of Electronic Publication: 2018 Dec 13.
Typ publikacji:
Journal Article
MeSH Terms:
Parturition*
Patient Selection*
Brain/*pathology
Dementia/*pathology
Aged ; Cohort Studies ; Female ; Humans ; London ; Male ; Socioeconomic Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer's disease.
Autorzy:
Sánchez-Valle R; Alzheimer's Disease and Other Cognitive Disorders Unit, Department of Neurology, Hospital Clínic, Institut d'Investigació Biomèdica August Pi i Sunyer, University of Barcelona, Villarroel, 170, 08036, Barcelona, Spain. .
Heslegrave A; Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, London, UK.
Foiani MS; Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, London, UK.
Bosch B; Alzheimer's Disease and Other Cognitive Disorders Unit, Department of Neurology, Hospital Clínic, Institut d'Investigació Biomèdica August Pi i Sunyer, University of Barcelona, Villarroel, 170, 08036, Barcelona, Spain.
Antonell A; Alzheimer's Disease and Other Cognitive Disorders Unit, Department of Neurology, Hospital Clínic, Institut d'Investigació Biomèdica August Pi i Sunyer, University of Barcelona, Villarroel, 170, 08036, Barcelona, Spain.
Balasa M; Alzheimer's Disease and Other Cognitive Disorders Unit, Department of Neurology, Hospital Clínic, Institut d'Investigació Biomèdica August Pi i Sunyer, University of Barcelona, Villarroel, 170, 08036, Barcelona, Spain.
Lladó A; Alzheimer's Disease and Other Cognitive Disorders Unit, Department of Neurology, Hospital Clínic, Institut d'Investigació Biomèdica August Pi i Sunyer, University of Barcelona, Villarroel, 170, 08036, Barcelona, Spain.
Zetterberg H; Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, London, UK.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Fox NC; UK Dementia Research Institute at UCL, London, UK.; Dementia Research Centre, University College of London, Institute of Neurology, London, UK.
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2018 Nov 03; Vol. 10 (1), pp. 113. Date of Electronic Publication: 2018 Nov 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Alzheimer Disease/*diagnosis
Neurofilament Proteins/*blood
Adult ; Alzheimer Disease/blood ; Alzheimer Disease/cerebrospinal fluid ; Alzheimer Disease/genetics ; Biomarkers/blood ; Biomarkers/cerebrospinal fluid ; Cross-Sectional Studies ; Female ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Mutation ; Neurofilament Proteins/cerebrospinal fluid ; Severity of Illness Index
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Secondary prevention of Alzheimer's dementia: neuroimaging contributions.
Autorzy:
Ten Kate M; Department of Radiology and Nuclear Medicine, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands. .; Alzheimer Center & Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, PO Box 7056, 1007 MB, Amsterdam, the Netherlands. .
Ingala S; Department of Radiology and Nuclear Medicine, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands.
Schwarz AJ; Takeda Pharmaceuticals Comparny, Cambridge, MA, USA.; Eli Lilly and Company, Indianapolis, Indiana, USA.
Fox NC; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.
Chételat G; Institut National de la Santé et de la Recherche Médicale, Inserm UMR-S U1237, Université de Caen-Normandie, GIP Cyceron, Caen, France.
van Berckel BNM; Department of Radiology and Nuclear Medicine, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands.
Ewers M; Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig-Maximilians-Universität LMU, Munich, Germany.
Foley C; GE Healthcare Life Sciences, Amersham, UK.
Gispert JD; Barcelonaβeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain.
Hill D; IXICO Plc, London, UK.
Irizarry MC; Eli Lilly and Company, Indianapolis, Indiana, USA.
Lammertsma AA; Department of Radiology and Nuclear Medicine, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands.
Molinuevo JL; Barcelonaβeta Brain Research Center, Pasqual Maragall Foundation, Barcelona, Spain.
Ritchie C; Centre for Dementia Prevention, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Scheltens P; Alzheimer Center & Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, PO Box 7056, 1007 MB, Amsterdam, the Netherlands.
Schmidt ME; Janssen Pharmaceutica NV, Beerse, Belgium.
Visser PJ; Alzheimer Center & Department of Neurology, Neuroscience Campus Amsterdam, VU University Medical Center, PO Box 7056, 1007 MB, Amsterdam, the Netherlands.
Waldman A; Centre for Dementia Prevention, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
Wardlaw J; Centre for Dementia Prevention, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.; Dementia Research Centre, University of Edinburgh, Edinburgh, UK.
Haller S; Affidea Centre de Diagnostic Radiologique de Carouge, Geneva, Switzerland.
Barkhof F; Department of Radiology and Nuclear Medicine, Neuroscience Campus Amsterdam, VU University Medical Center, Amsterdam, the Netherlands.; Insititutes of Neurology and Healthcare Engineering, University College London, London, UK.
Pokaż więcej
Źródło:
Alzheimer's research & therapy [Alzheimers Res Ther] 2018 Oct 30; Vol. 10 (1), pp. 112. Date of Electronic Publication: 2018 Oct 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Alzheimer Disease/*diagnostic imaging
Alzheimer Disease/*prevention & control
Brain/*diagnostic imaging
Neuroimaging/*methods
Biomarkers ; Brain/pathology ; Brain/physiopathology ; Disease Progression ; Humans ; Longitudinal Studies ; Secondary Prevention
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 129

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies